Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

OncoCyte Corporation

TRADE

AMEX: OCXHealthcare / Diagnostic Substances / California, U.S.A
2.01-0.02-0.99%Vol 82 5771Y Perf -68.35%
Oct 16th, 2018 16:00
BID2.01 ASK0.00
Open2.03 Previous Close2.03
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.25 
Analyst Rating
Moderate Buy 1.67
Potencial %
210.95 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)82 
Earnings Rating
Sell
Price Range Ratio 52wk %
16.37 
Earnings Date
13th Nov 2018

Today's Price Range

1.962.15

 

52wk Range

1.106.66

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-12.61%
3 Months
-29.47%
6 Months
-29.47%
1 Year
-68.35%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
OCX2.01-0.0200-0.99
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.50
Current Ratio 2.50
Long Term Debt to Total Capital 0.11
Total Debt to Equity 0.29
Interest Coverage -335.80
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 12.59
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -8.60
Cash Flow Per Share -0.41
Price to Tangible Book12.59
Book Value per Share0.17
Enterprise Value (in ths.)77 162
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-170.09
ROE last 12 Months -303.66
Return on Assets (5Y Avg) -78.73
ROA last 12 Months -155.61
Return on Capital (5Y Avg) -131.36
ROC last 12 Months -223.90
Return on invested Capital Q -44.87
Return on invested Capital Y-224.33
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.10-0.12-20.00
Q01 2018-0.13-0.127.69
Q04 2017--0.13-
Q03 2017-0.13-0.127.69
Q02 2017-0.12-0.13-8.33
Q01 2017-0.13-0.16-23.08
Q04 2016-0.10-0.11-10.00
Q03 2016-0.10-0.100.00
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.090.00-
12/2018 QR-0.090.00-
12/2018 FY-0.41-2.50Negative
12/2019 FY-0.426.67Positive
Next Report Date13th Nov 2018
Estimated EPS Next Report-0.09
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume82 577
Shares Outstanding (in ths.)40 660
Trades Count195
Dollar Volume168 754
Avg. Volume73 119
Avg. Weekly Volume52 599
Avg. Monthly Volume44 305
Avg. Quarterly Volume51 498

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x